ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
ACHIEVE LIFE SCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$6.61+0.23 (+3.53%)
Close on Oct 19, 2026
- Market cap
- $617.64M
- P/E (TTM)
- –
- Dividend yield
- –
Achieve Life Sciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of In Vitro & In Vivo Diagnostic Substances companies for comparison
Valuation
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Market Cap | $679.67M | $166.30M |
| Enterprise Value | $492.37M | $88.19M |
Income (trailing twelve months)
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Net Income | -$114.04M | -$22.46M |
| EPS (Diluted) | -$1.54 | -$0.83 |
Returns
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -845.0% | -53.2% |
| Return on Assets (ROA) | -91.5% | -40.9% |
Balance sheet
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $187.30M | $61.43M |
| Net Cash (Debt) | $187.30M | $15.35M |
| Net Cash Per Share | $1.82 | $0.66 |
| Equity (Book Value) | -$14.68M | $49.09M |
| Book Value Per Share | -$0.14 | $1.37 |
| Tangible Book Value | -$16.35M | $23.52M |
| Working Capital | -$9.36M | $76.81M |
Financial position
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Current Ratio | 0.95 | 3.34 |
| Quick Ratio | 0.95 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$47.02M | -$12.35M |
Efficiency
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Profits Per Employee | -$4.07M | -$703.34K |
| Employee Count | 28 | 74 |
Dividends and yields
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Earnings Yield | -16.8% | -23.3% |
Shares
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Shares Outstanding | 102,902,000 | 58,127,000 |
| Shares Change (YoY) | 82.1% | 10.9% |
| Shares Change (QoQ) | 92.9% | 0.54% |
| Float | 77,240,300 | 49,136,700 |
| Shares Held by Insiders | 24.9% | 11.6% |
| Shares Held by Institutions | 80.3% | 59.4% |
Scores
| Measure | Achieve Life Sciences | Industry median |
|---|---|---|
| Altman Z-Score | -0.61 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Achieve Life Sciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.